×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Practical Implementation of MRCTs Based on ICH E17 Guidelines
Session Chair(s)
Yoshiaki Uyama, PhD, MS, RPh
Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Hear directly from the regulators and industry about the challenges and opportunities in applying the ICH E17 guidelines. Some cases based on ICH E17 guidelines will be presented in the panel. Panelists will be asked to make comments for each case regarding points to consider in planning a study or evaluating results.
Learning Objective : Explore how ICH E17 guidelines are being implemented in the conduct of multiregional clinical trials; Evaluate the limitations, gaps, and opportunities for applying the guideline globally.
Speaker(s)
Panelist
Representative Invited
Hannover Medical School, Germany
Panelist
Adriane Alves de Oliveira, MSc
Brazilian Health Regulatory Agency (ANVISA), Brazil
Health Regulation Expert
Panelist
Representative Invited
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Panelist
William Wang, PhD
Merck & Co, Inc, United States
Executive Director
Have an account?